Description:

MRUS is the ticker symbol for Mirati Therapeutics Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company specializes in developing targeted therapies for patients with cancer. Mirati's focus lies in advancing novel medicines that address unmet medical needs, particularly in areas where there is a high level of unmet patient need and scientific complexity. Through its robust pipeline and innovative research, Mirati aims to transform the treatment landscape for various cancers, offering hope to patients and their families.

Data:

Yields: